These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 22249448)
1. TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J. Zhao B; Grimes SN; Li S; Hu X; Ivashkiv LB J Exp Med; 2012 Feb; 209(2):319-34. PubMed ID: 22249448 [TBL] [Abstract][Full Text] [Related]
2. RBP-J-Regulated miR-182 Promotes TNF-α-Induced Osteoclastogenesis. Miller CH; Smith SM; Elguindy M; Zhang T; Xiang JZ; Hu X; Ivashkiv LB; Zhao B J Immunol; 2016 Jun; 196(12):4977-86. PubMed ID: 27183593 [TBL] [Abstract][Full Text] [Related]
3. RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis. Li S; Miller CH; Giannopoulou E; Hu X; Ivashkiv LB; Zhao B J Clin Invest; 2014 Nov; 124(11):5057-73. PubMed ID: 25329696 [TBL] [Abstract][Full Text] [Related]
4. Regulatory network mediated by RBP-J/NFATc1-miR182 controls inflammatory bone resorption. Inoue K; Hu X; Zhao B FASEB J; 2020 Feb; 34(2):2392-2407. PubMed ID: 31908034 [TBL] [Abstract][Full Text] [Related]
5. Intrinsic Restriction of TNF-Mediated Inflammatory Osteoclastogenesis and Bone Resorption. Zhao B Front Endocrinol (Lausanne); 2020; 11():583561. PubMed ID: 33133025 [TBL] [Abstract][Full Text] [Related]
6. Intravenous Immunoglobulin (IVIG) Attenuates TNF-Induced Pathologic Bone Resorption and Suppresses Osteoclastogenesis by Inducing A20 Expression. Lee MJ; Lim E; Mun S; Bae S; Murata K; Ivashkiv LB; Park-Min KH J Cell Physiol; 2016 Feb; 231(2):449-458. PubMed ID: 26189496 [TBL] [Abstract][Full Text] [Related]
7. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189 [TBL] [Abstract][Full Text] [Related]
8. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis. Kanazawa K; Kudo A J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857 [TBL] [Abstract][Full Text] [Related]
9. Jagged1 Acts as an RBP-J Target and Feedback Suppresses TNF-Mediated Inflammatory Osteoclastogenesis. Ng C; Qin Y; Xia Y; Hu X; Zhao B J Immunol; 2023 Nov; 211(9):1340-1347. PubMed ID: 37756541 [TBL] [Abstract][Full Text] [Related]
10. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo. Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094 [TBL] [Abstract][Full Text] [Related]
11. Acteoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-κB pathway and attenuating ROS production. Lee SY; Lee KS; Yi SH; Kook SH; Lee JC PLoS One; 2013; 8(12):e80873. PubMed ID: 24324641 [TBL] [Abstract][Full Text] [Related]
12. NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. Yamashita T; Yao Z; Li F; Zhang Q; Badell IR; Schwarz EM; Takeshita S; Wagner EF; Noda M; Matsuo K; Xing L; Boyce BF J Biol Chem; 2007 Jun; 282(25):18245-18253. PubMed ID: 17485464 [TBL] [Abstract][Full Text] [Related]
13. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis. Miyauchi Y; Ninomiya K; Miyamoto H; Sakamoto A; Iwasaki R; Hoshi H; Miyamoto K; Hao W; Yoshida S; Morioka H; Chiba K; Kato S; Tokuhisa T; Saitou M; Toyama Y; Suda T; Miyamoto T J Exp Med; 2010 Apr; 207(4):751-62. PubMed ID: 20368579 [TBL] [Abstract][Full Text] [Related]
14. Water extract of Spatholobus suberectus inhibits osteoclast differentiation and bone resorption. Ha H; Shim KS; An H; Kim T; Ma JY BMC Complement Altern Med; 2013 May; 13():112. PubMed ID: 23692684 [TBL] [Abstract][Full Text] [Related]
15. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically. Valverde P; Tu Q; Chen J J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638 [TBL] [Abstract][Full Text] [Related]
16. Blimp1-mediated repression of negative regulators is required for osteoclast differentiation. Nishikawa K; Nakashima T; Hayashi M; Fukunaga T; Kato S; Kodama T; Takahashi S; Calame K; Takayanagi H Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3117-22. PubMed ID: 20133620 [TBL] [Abstract][Full Text] [Related]
17. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss. Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498 [TBL] [Abstract][Full Text] [Related]
19. Agrimophol suppresses RANKL-mediated osteoclastogenesis through Blimp1-Bcl6 axis and prevents inflammatory bone loss in mice. Cao J; Wang S; Wei C; Lin H; Zhang C; Gao Y; Xu Z; Cheng Z; Sun WC; Wang HB Int Immunopharmacol; 2021 Jan; 90():107137. PubMed ID: 33199235 [TBL] [Abstract][Full Text] [Related]
20. C/EBPα transcription factor is regulated by the RANK cytoplasmic Jules J; Chen W; Feng X; Li YP J Biol Chem; 2018 Jan; 293(4):1480-1492. PubMed ID: 29122885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]